Internal medicine

Occlusion

Disease

Atrial fibrillation

Coronavirus disease 2019 (COVID-19)

Infectious disease (medical specialty)

Outbreak

Cardiology

Blood flow

Virology

Warfarin

Rivaroxaban

2019-20 coronavirus outbreak

Apixaban

Ophthalmic artery

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Medicine

Journal of Stroke and Cerebrovascular Diseases

Ischemic stroke is a rising neurological complication of COVID-19 infection.1–3 Previously reported ophthalmic findings in COVID-19 patients are mainly ocular surface disorders 4,5 and ocular vascular complications have not yet been reported. Ophthalmic artery occlusion (OAO) is a carotid circulation ischemic stroke syndrome. We report a case of acute OAO in a young patient with a severe form of COVID-19 infection that was on therapeutic anticoagulation with apixaban for deep venous thrombosis (DVT).

Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban